Max Healthcare: AGM on July 30, Record Date July 3 for Final Dividend
Max Healthcare will hold its AGM on July 30, 2026. The record date for the final dividend for FY25-26 is July 3, 2026. A final dividend of ₹2.00 per share was recommended. Communications regarding TDS on dividend were sent on June 19, 2026, with a submission deadline of July 10, 2026.
The announcement concerns the final dividend and AGM, which are important events for shareholders. The detailed information on TDS implications also requires attention from investors.
The announcement is a routine corporate communication regarding the AGM, record date for dividend, and tax implications. It does not contain any new financial performance data or strategic changes that would significantly impact the sentiment.
Max Healthcare Institute Limited has announced that its Twenty-Fifth (25th) Annual General Meeting (AGM) is scheduled to be held on Thursday, July 30, 2026, via video conference. The company has fixed Friday, July 3, 2026, as the 'Record Date' for determining the eligibility of members to receive the final dividend for the financial year 2025-26, subject to its approval at the AGM.
The Board of Directors had previously recommended a final dividend of ₹2.00 per equity share (20%) for FY ended March 31, 2026. The company has also sent communications to its members on June 19, 2026, detailing the process and documentation required for claiming exemption from Tax Deduction at Source (TDS) on this final dividend. Detailed information regarding TDS rates and the necessary forms (including Form 121 for resident members and various declarations for non-resident members) for claiming treaty benefits or exemptions has been provided, with a submission deadline of Friday, July 10, 2026, to the company's Registrar and Transfer Agent, MUFG Intime India Private Limited. Members are advised to consult their tax advisors.
What to do with a filing like this
Max Healthcare Institute Limited filed this with the NSE as a statutory disclosure, categorised under agm. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Max Healthcare Institute Limited. Read the original for the full detail.